Researchers presented a first step in the direction of developing a minimally invasive treatment strategy for peripheral lung cancer and metastatic lymph nodes of advanced lung cancer by using nanoparticles targeting the scavenger receptor class B type I (SR-BI) that is expressed on the lung cancer cells. The gene discussed is SCARB1; the disease is lung carcinoma.